HOSPITAL SPECIALTY EQUIPMENT, LLC

Capabilities

Genesis Air subjected their patented air purification technology to challenge testing with the SARS-CoV-2 active virus in the BSL-4 Galveston National Laboratory. SARS-CoV-2, an enveloped RNA virus, has the potential to exist in both droplet and aerosol forms. It has also been studied and confirmed to be infective six to seven feet from the source (1-7). Therefore, technologies that can inactivate the virus in spaces where individuals are within close proximity is essential to creating safer indoor environments. Most transmission of the SARS virus occurs indoors and between people in close proximity to each other (8). Technologies that either clean the air and surfaces (i.e., disinfectants) and/or cannot be used when people are present (i.e., exposed ultraviolet (UV) radiation) have limited application and cannot treat the indoor environment when it is most critical, i.e., when it is occupied.